Publications by authors named "Hermann Russ"

Claim this Profile
A
Author Correction: The preferences of people with amyotrophic lateral sclerosis on riluzole treatment in Europe.
Albert C Ludolph, Harish Grandjean, Evy Reviers, Valentina De Micheli, Cosetta Bianchi, Hermann Russ

Sci Rep· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GAL-201 as a Promising Amyloid-β-Targeting Small-Molecule Approach for Alzheimer's Disease Treatment: Consistent Effects on Synaptic Plasticity, Behavior and Neuroinflammation.
Katrin Riemann, Jeldrik von Ahsen, Tamara Böhm, Martin Schlegel, Matthias Kreuzer, Hermann Russ

Int J Mol Sci· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The preferences of people with amyotrophic lateral sclerosis on riluzole treatment in Europe.
Albert C Ludolph, Harish Grandjean, Evy Reviers, Valentina De Micheli, Cosetta Bianchi, Hermann Russ

Sci Rep· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Small Molecule GAL-201 Efficiently Detoxifies Soluble Amyloid β Oligomers: New Approach towards Oral Disease-Modifying Treatment of Alzheimer's Disease.
Hermann Russ, Michele Mazzanti, Chris Parsons, Katrin Riemann, Alexander Gebauer

Int J Mol Sci· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Visual Field Endpoints Based on Subgroups of Points May Be Useful in Glaucoma Clinical Trials: A Study With the Humphrey Field Analyzer and Compass Perimeter.
Yaniv Barkana, Ari Leshno, Ori Stern, Reut Singer, Hermann Russ

J Glaucoma· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved sensitivity of microperimetric outcomes for clinical studies in age-related macular degeneration.
Yaniv Barkana, Susanne G Pondorfer, Steffen Schmitz-Valckenberg, Hermann Russ, Robert P Finger

Sci Rep· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MRZ-99030 - A novel modulator of Aβ aggregation: I - Mechanism of action (MoA) underlying the potential neuroprotective treatment of Alzheimer's disease, glaucoma and age-related macular degeneration (AMD).
Christopher G Parsons, Maarten Ruitenberg, Christine E Freitag, Kamila Sroka-Saidi, Hermann Russ

Neuropharmacology· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of neramexane in patients with moderate to severe subjective tinnitus.
Markus Suckfüll, Michael Althaus, Barbara Ellers-Lenz, Alexander Gebauer, Roman Görtelmeyer, Hermann Russ

BMC Ear Nose Throat Disord· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The management approaches to dyskinesia vary from country to country.
Dirk Woitalla, Thomas Mueller, Hermann Russ, Klaus Hock, Doris-Anita Haeger

Neuroepidemiology· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Placebo influences on dyskinesia in Parkinson's disease.
Christopher G Goetz, Eugene Laska, Christine Hicking, Philippe Damier, Thomas Müller, Hermann Russ

Mov Disord· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sarizotan as a treatment for dyskinesias in Parkinson's disease: a double-blind placebo-controlled trial.
Christopher G Goetz, Philippe Damier, Christine Hicking, Eugene Laska, Thomas Müller, Hermann Russ

Mov Disord· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient evaluation of a home diary to assess duration and severity of dyskinesia in Parkinson disease.
Robert A Hauser, Hermann Russ, Doris-Anita Haeger, Michel Bruguiere-Fontenille, Thomas Müller

Clin Neuropharmacol· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Levodopa, motor fluctuations and dyskinesia in Parkinson's disease.
Thomas Müller, Hermann Russ

Expert Opin Pharmacother· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter, open-label, trial of sarizotan in Parkinson disease patients with levodopa-induced dyskinesias (the SPLENDID Study).
C Warren Olanow, Philippe Damier, Christopher G Goetz, Thomas Mueller, John Nutt, Hermann Russ

Clin Neuropharmacol· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis